Is the performance of ImmunoCAP ISAC 112 sufficient to diagnose peach and apple allergies?

Abstract

Food allergies constitute a public health issue, with a reported overall estimated prevalence of 6% in Europe1 and Rosacea as the main allergenic fruits among adults.2 The commercial microarray ImmunoCAP ISAC 112 (Thermofisher, Uppsala, Sweden) is a semiquantitative and reproducible in vitro diagnostic tool used for the determination of specific IgE (sIgE).3 However, its panel of allergens does not have the best accuracy when it comes to determining fruit allergies in the Mediterranean area: the inclusion of the thaumatinlike protein (TLP) Pru p 2 or the apple lipid transfer protein (LTP) Mal d 3 has been proposed to improve the diagnosis of peach4 and apple5 allergies, respectively, in the Mediterranean basin. We sought to determine the usefulness of a component-resolved microarray for the diagnosis of peach and apple allergies in the Mediterranean area.